-
TWO-YEAR COST ANALYSIS OF COMMON HEAD AND NECK CANCERS - INDEX PROCEDURES AND ADJUVANT THERAPIES
Feb 25, 2026, 14:42 PM -
PROVISIONAL PRICING IN MEDICINE POLICY: GLOBAL BENCHMARKING
Feb 25, 2026, 14:42 PM -
EFFECT OF ANTIHYPERTENSIVE USE ON FALL RISK
Feb 25, 2026, 14:42 PM -
USE OF REAL-WORLD EVIDENCE ON US BRANDED HCP DRUG WEBSITES: AN AI-ENABLED CONTENT ANALYSIS
Feb 25, 2026, 14:42 PM -
COMPARING METHODOLOGICAL AND REPORTING STANDARDS FOR HEALTH ECONOMIC EVALUATION: INSIGHTS FROM NICE TSD 15, ISPOR GOOD PRACTICES, AND CHEERS 2022 GUIDELINES
Feb 25, 2026, 14:42 PM -
FROM RETRIEVAL TO VERDICT: A HYBRID LLM PIPELINE FOR EVALUATING MEDICAL AND ECONOMIC CLAIMS
Feb 25, 2026, 14:42 PM -
WHAT HEOR CAN LEARN FROM MATURE AI INDUSTRIES AND WHERE THE ANALOGIES BREAK DOWN
Feb 25, 2026, 14:42 PM -
DISTANCE FROM HEALTH CARE FACILITY AND OTHER VARIABLES IMPACT TIME TO CELIAC DISEASE DIAGNOSIS
Feb 25, 2026, 14:42 PM -
SHEDDING LIGHT ON PATIENT-REPORTED OUTCOME MEASURE UTILIZATION ACROSS NSCLC THERAPIES
Feb 25, 2026, 14:42 PM -
THE IMPACT OF GLYCEMIC CONTROL AND MEDICATION ADHERENCE ON HOSPITALIZATION RISK IN TYPE 2 DIABETES: A LONGITUDINAL REAL-WORLD EVIDENCE STUDY FROM THE LITHUANIAN NATIONAL HEALTH INSURANCE FUND ADMINISTRATIVE DATA
Feb 25, 2026, 14:42 PM -
REAL-WORLD MULTIPLE MYELOMA TREATMENT RESPONSES: EVALUATION OF FRONTLINE REGIMENS IN MELDTM LINKED MEDICARE, LABORATORY AND ELECTRONIC MEDICAL RECORDS...
Feb 25, 2026, 14:42 PM -
MIND THE GAP: ARTIFICIAL INTELLIGENCE (AI) POWERED ANALYSIS OF DECISION DRIVERS WITHIN ULTRA-RARE DISEASE/HST NICE TECHNOLOGY APPRAISALS
Feb 25, 2026, 14:42 PM -
PATIENT-CENTERED ENDPOINT STRATEGY FOR BIOLOGIC TRIALS IN SEVERE ASTHMA: INTEGRATING REGULATORY, PAYER, AND PATIENT PRIORITIZED ENDPOINTS
Feb 25, 2026, 14:42 PM -
REAL-WORLD EFFECTIVENESS OF DUPILUMAB IN REDUCING ORAL AND INHALED CORTICOSTEROID USE AMONG US PATIENTS WITH ASTHMA: ANALYSIS FROM THE HEALTHCARE INTEGRATED RESEARCH DATABASE
Feb 25, 2026, 14:42 PM -
GIVE ME THE NUMBERS: FINE-GRAINED, STRUCTURED DATA EXTRACTION BEYOND NARRATIVE LLM OUTPUTS
Feb 25, 2026, 14:42 PM -
REAL-WORLD DATA ON OUTCOMES AND COSTS AMONG PATIENTS WITH PRIOR CARDIOVASCULAR EVENTS IN THE BRAZILIAN PRIVATE HEALTH SYSTEM
Feb 25, 2026, 14:42 PM -
NATIONAL TRENDS IN OPIOID, BENZODIAZEPINE AND ANTICHOLINERGIC ORDERS IN LONG-TERM CARE
Feb 25, 2026, 14:42 PM -
NEUROLOGIST PREFERENCES FOR NEW MS TREATMENTS: IMPLICATIONS FOR MARKET ACCESS PRIORITIZATION IN THE UNITED STATES AND EUROPE
Feb 25, 2026, 14:42 PM -
INDIVIDUAL PREFERENCES FOR UPPER EXTREMITY PROSTHETICS ALONG A USER-COMPLEXITY FRAMEWORK: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:42 PM -
INTEGRATING SOCIAL DETERMINANTS OF HEALTH INTO GLP-1 VALUE ASSESSMENT: A PROPOSED DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS FRAMEWORK
Feb 25, 2026, 14:42 PM
